A new NGS-based method for chimerism monitoring
In this case study, you will hear Dr. Dan Hauzenberger, Medical Director, Section of Transplantation Immunology at Sweden’s Karolinska University Hospital, describing how new, highly sensitive, and precise methods for mixed chimerism analytics are transforming post-transplant monitoring, enabling earlier detection and treatment to save the lives of transplanted.
- Very early detection of relapse is possible thanks
to high sensitivity and accurate measurement
down to 0.05% minority fraction chimerism. - Fast and easy workflow from patient sample to report.
- One tube NGS library prep with just 45 minutes
hands-on time combined with powerful and
intuitive data analysis and reporting software.
Get access to the case study by filling out the form below
A new NGS-based method for chimerism monitoring
In this case study, you will hear Dr. Dan Hauzenberger, Medical Director, Section of Transplantation Immunology at Sweden’s Karolinska University Hospital, describing how new, highly sensitive, and precise methods for mixed chimerism analytics are transforming post-transplant monitoring, enabling earlier detection and treatment to save the lives of transplanted.
- Very early detection of relapse is possible thanks
to high sensitivity and accurate measurement
down to 0.05% minority fraction chimerism. - Fast and easy workflow from patient sample to report.
- One tube NGS library prep with just 45 minutes
hands-on time combined with powerful and
intuitive data analysis and reporting software.
Related content
View allDevyser Diagnostics AB publishes quarterly report for the period April to June 2024
“Devyser continued to report high sales growth in the second quarter. Organic growth compared with...
Read More
Devyser wins tender in Italy for its cystic fibrosis NGS test worth up to 5.9 million SEK
Read More
Devyser wins tender in Sweden for Thalassemia NGS testing worth up to 8.4 million SEK
Read More